Literature DB >> 19258956

Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma.

Evis Sala1, Robin Crawford, Emma Senior, Ashley Shaw, Bryony Simcock, Kalliopi Vrotsou, Christopher Palmer, Pauline Rajan, Ilse Joubert, David Lomas.   

Abstract

AIM: To assess the added value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in predicting advanced stage disease in patients with endometrial carcinoma.
MATERIALS AND METHODS: Fifty patients with endometrial carcinoma underwent preoperative MRI assessment in a single gynecological cancer center during a 2-year period. Magnetic resonance imaging examinations included high-resolution sagittal, axial, and axial-oblique T2-weighted images (T2WI) of the pelvis, and axial T1-weighted images (T1WI) of the pelvis and upper abdomen followed by DCE-MRI using a multiphase 3-dimensional gradient refocused echo T1WI sequence. The T2W images were evaluated initially, and local and overall staging was assigned according to the FIGO classification. An identical scoring system was used to evaluate the combination of DCE-MRI and T2WI. The presence of potential pitfalls in the accurate assessment of depth of myometrial invasion (leiomyoma, adenomyosis, loss of junctional zone definition, polypoid tumor, poor tumor-to-myometrium contrast, and tumor extension to uterine cornu) was also recorded. Surgical histology constituted the standard of reference.
RESULTS: The depth of myometrial invasion was correctly determined in 78% (39/50) of the cases on T2WI alone, increasing to 92% (46/50) with the addition of DCE-MRI (95% confidence interval for improvement, 4.4%-23.6%, P = 0.016). The addition of DCE-MRI led to the correct detection of deep myometrial invasion in all cases. Tumor extension to uterine cornu was the only variable significantly associated (P = 0.014) with incorrect estimation of depth of myometrial invasion.
CONCLUSIONS: The addition of multiphase 3-dimensional DCE-MRI to T2WI can effectively assess the depth of myometrial invasion in endometrial carcinoma and may be a useful tool to guide the surgical approach.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258956     DOI: 10.1111/IGC.0b013e3181995fd9

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  18 in total

1.  Advances in magnetic resonance imaging of endometrial cancer.

Authors:  Evis Sala; Andrea Rockall; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

Review 2.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

Review 3.  Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies.

Authors:  Lian-Ming Wu; Jian-Rong Xu; Hai-Yan Gu; Jia Hua; E Mark Haacke; Jiani Hu
Journal:  Eur Radiol       Date:  2012-08-04       Impact factor: 5.315

4.  Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma.

Authors:  Junyu Guo; Wilburn E Reddick; John O Glass; Qing Ji; Catherine A Billups; Jianrong Wu; Fredric A Hoffer; Sue C Kaste; Jesse J Jenkins; Ximena C Ortega Flores; Juan Quintana; Milena Villarroel; Najat C Daw
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

5.  Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists.

Authors:  Ingfrid S Haldorsen; Jenny A Husby; Henrica M J Werner; Inger J Magnussen; Jarle Rørvik; Harald Helland; Jone Trovik; Øyvind O Salvesen; Ansgar Espeland; Helga B Salvesen
Journal:  Eur Radiol       Date:  2012-03-28       Impact factor: 5.315

6.  Application of FLASH-3D dynamic contrast-enhanced imaging for diagnosis of endometrial carcinoma.

Authors:  Lixin Du; Xiaohu Li; Xixiong Qiu; Xiaolei Liu; Yuli Wang; Yongqiang Yu
Journal:  Br J Radiol       Date:  2016-07-26       Impact factor: 3.039

7.  Dynamic contrast-enhanced MR imaging of endometrial cancer: optimizing the imaging delay for tumour-myometrium contrast.

Authors:  Sung Bin Park; Min Hoan Moon; Chang Kyu Sung; Sohee Oh; Young Ho Lee
Journal:  Eur Radiol       Date:  2014-07-24       Impact factor: 5.315

8.  Magnetic resonance imaging for detection of depth of myometrial invasion and cervical invasion in patients with endometrial carcinoma.

Authors:  Xiang-Hua Yin; Hong-Yan Jia; Min Shi; Huan Wu; Yun-Mo Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer.

Authors:  Gaiane M Rauch; Harmeet Kaur; Haesun Choi; Randy D Ernst; Ann H Klopp; Piyaporn Boonsirikamchai; Shannon N Westin; Leonardo P Marcal
Journal:  Radiographics       Date:  2014 Jul-Aug       Impact factor: 5.333

10.  Endometrial cancer: preoperative staging using three-dimensional T2-weighted turbo spin-echo and diffusion-weighted MR imaging at 3.0 T: a prospective comparative study.

Authors:  Masatoshi Hori; Tonsok Kim; Hiromitsu Onishi; Izumi Imaoka; Yuki Kagawa; Takamichi Murakami; Atsushi Nakamoto; Takashi Ueguchi; Mitsuaki Tatsumi; Takayuki Enomoto; Tadashi Kimura; Noriyuki Tomiyama
Journal:  Eur Radiol       Date:  2013-03-19       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.